Tags

, , , , , , , , , , ,


Sallix Pharmaceuticals bought out Santarus – a competitor to Sallix – for $32.00 a share, driving up shares of Santarus. With the surge of Santarus stock, many Pharmaceutical stocks followed suit. Ultimately, yesterday was security and defense stocks, today is pharmaceutical stocks, two days ago it was video game stocks, and finally three days ago it was Tesla and Tech stocks. The market changes everyday, the key in this is to be able to identify which part of the market is going to shoot up which day. Just a thought.

Advertisements